Skip to main content
$3.01 -$0.01 (-0.3%)

04:00 PM EST on 12/07/22

23andMe Holding Co. (NASDAQ:ME)

CAPS Rating: 2 out of 5

23andMe, Inc., headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, 23andMe's mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple Food and Drug Administration authorizations for genetic health risk reports. 23andMe has created the world's largest crowdsourced platform for genetic research, with 80% of its customers electing to participate.

Current Price $3.01 Mkt Cap $1.4B
Open $3.00 P/E Ratio 0.00
Prev. Close $3.01 Div. (Yield) $0.00 (0.0%)
Daily Range $2.97 - $3.10 Volume 1,849,174
52-Wk Range $2.12 - $8.86 Avg. Daily Vol. 2,609,055

Caps

How do you think NASDAQ:ME will perform against the market?

Add Stock to CAPS Watchlist

All Players

34 Outperform
5 Underperform
 

All-Star Players

4 Outperform
4 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ME Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFJaguar (44.43)
Submitted January 14, 2022

High risk because the core business doesn't generate positive cash flow. High reward because the company should have the highest quality genetic dataset around. With advancement in data analytics over the next 5 to 10 years, I don't see how this… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:ME Summary

  • Sector:
  • Industry:
  • Tags:

Fools bullish on NASDAQ:ME are also bullish on:

Fools bearish on NASDAQ:ME are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ME.

Recs

0
Member Avatar UncannyHoosier (29.65) Submitted: 11/7/2022 2:24:04 PM : Outperform Start Price: $2.94 NASDAQ:ME Score: -1.23

upcoming

Recs

0
Member Avatar Har1en (99.41) Submitted: 10/1/2022 5:18:47 PM : Outperform Start Price: $2.95 NASDAQ:ME Score: -6.85

Just heard the CEO speak, and I'm with her on the idea that the only way genomics moves forward is with consumer control over their own data. 23andMe seems to be best positioned in the industry, and they seem to be actually helping people live better, fuller, longer lives. However, this company is a money pit. I think if they can figure out how to actually stabilize in the next 24 months, we are off to the races. Otherwise... they're heading for pain. Raising money in this market downturn will be hard. Individual investors may not see great returns because of this, however, for humanity, I hope this company survives and does great things.

Recs

2
Member Avatar TMFJaguar (44.43) Submitted: 1/14/2022 1:51:35 PM : Outperform Start Price: $5.00 NASDAQ:ME Score: -25.97

High risk because the core business doesn't generate positive cash flow. High reward because the company should have the highest quality genetic dataset around. With advancement in data analytics over the next 5 to 10 years, I don't see how this won't be valuable. At its current price, it's trading at around a $2.3 billion market cap with over $700 million in cash, substantial cushion and downside mitigation. Not a sure thing, but if a drug is a winner, this will likely be a multibagger.

Leaderboard

Find the members with the highest scoring picks in ME.

Score Leader

chammond55

chammond55 (94.99) Score: +60.76

The Score Leader is the player with the highest score across all their picks in ME.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
elektragreen159 80.49 8/13/2021 Underperform 5Y $7.63 -60.55% -11.75% +48.80 0 Comment
TMFJoryko 81.91 6/10/2022 Outperform 5Y $2.16 +39.35% +0.77% +38.58 0 Comment
Under5b < 20 9/27/2022 Underperform 5Y $3.06 -1.63% +6.83% +8.47 0 Comment
MylesPatrick 82.85 11/11/2022 Underperform 1Y $3.19 -5.64% -0.52% +5.12 0 Comment
UncannyHoosier 29.65 11/7/2022 Outperform 5Y $2.94 +2.38% +3.62% -1.23 1 Comment
valari25 99.84 11/21/2022 Underperform 5Y $2.90 +3.97% -0.34% -4.31 0 Comment
Under5 60.83 10/4/2022 Outperform 5Y $3.07 -1.95% +4.73% -6.69 0 Comment
Har1en 99.41 10/3/2022 Outperform 5Y $2.95 +2.03% +8.88% -6.85 1 Comment
XMFFlygal 96.72 11/22/2022 Underperform 3W $2.82 +6.93% -1.44% -8.37 0 Comment
tradingfool1 27.35 2/2/2022 Outperform 5Y $4.57 -34.14% -13.43% -20.70 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ME.